GlassScriptPhysician profile
Arjun Ramprasad
NPI 1992125413
$1,141.46
in general payments reported to CMS, 2019-2025
14 companies · $451 in 2025
The $451 reported for 2025 was more than what 81% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $34.21 · 2023: $306 · 2024: $79.03 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $320.64 | 2019-2025 | Infinity, Augment Injectable |
| Hydrocision, INC. | $143.90 | 2025 | Tenjet |
| Bioventus LLC | $136.36 | 2023 | Durolane |
| Alexion Pharmaceuticals, INC. | $126.10 | 2025 | |
| Ferring Pharmaceuticals INC. | $118.19 | 2019 | |
| Depuy Synthes Sales INC. | $55.12 | 2023-2025 | Monovisc |
| Zyla Life Sciences, INC. | $47.22 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $43.02 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Sanofi-Aventis U.S. LLC | $42.62 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $32.32 | 2025 | |
| Tersera Therapeutics LLC | $24.04 | 2019 | |
| Ermi LLC | $23.14 | 2019 | |
| Solventum Corporation | $16.96 | 2024 | Prevena |
| Heraeus Medical, LLC. | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Ramprasad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.